Clinical Trial Update: Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) [Phase 4]

View source ↗

Summary

A phase 4 prospective cohort study evaluating real-life effectiveness of the glycopyrronium and indacaterol combination for COPD in Canada; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• glycopyrronium/indacaterol

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-06-24